Stockscreener 앱 받기
13.82
1.54%
0.225
Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스
Aldosterone Synthase Inhibitors Market is evolving rapidly - openPR.com
What catalysts could drive Mineralys Therapeutics Inc. stock higher in 2025Unlock exclusive stock market forecasts - jammulinksnews.com
How volatile is Mineralys Therapeutics Inc. stock compared to the marketUnlock your trading potential today - jammulinksnews.com
Will Mineralys Therapeutics Inc. stock split in the near futureTrend Analysis for Safer Trades Gains Popularity - metal.it
Is Mineralys Therapeutics Inc. a growth stock or a value stockExceptional market positioning - jammulinksnews.com
How many analysts rate Mineralys Therapeutics Inc. as a “Buy”Dynamic capital growth - jammulinksnews.com
Why is Mineralys Therapeutics Inc. stock attracting strong analyst attentionOutstanding trading profits - jammulinksnews.com
What are the latest earnings results for Mineralys Therapeutics Inc.Get real-time updates on market trends - jammulinksnews.com
What are Mineralys Therapeutics Inc. company’s key revenue driversAchieve breakthrough financial results - jammulinksnews.com
What are the technical indicators suggesting about Mineralys Therapeutics Inc.Unrivaled growth potential - jammulinksnews.com
Is Mineralys Therapeutics Inc. stock overvalued or undervaluedCapitalize on market shifts with expert advice - jammulinksnews.com
What is Mineralys Therapeutics Inc. company’s growth strategyPowerful market insights - jammulinksnews.com
How strong is Mineralys Therapeutics Inc. company’s balance sheetBuild a portfolio that grows with the market - jammulinksnews.com
Does Mineralys Therapeutics, Inc. (MLYS) Have the Potential to Rally 154.21% as Wall Street Analysts Expect? - Zacks Investment Research
What analysts say about Mineralys Therapeutics Inc. stockSuperior risk-adjusted returns - PrintWeekIndia
Mineralys Therapeutics, Inc. (MLYS) Upgraded to Buy: Here's Why - Yahoo Finance
Is Mineralys Therapeutics Inc. stock overhyped or has real potentialHigh-octane financial growth - jammulinksnews.com
Mineralys Therapeutics Inc. Stock Analysis and ForecastLightning-fast capital gains - Autocar Professional
How high can Mineralys Therapeutics Inc. stock price go in 2025Breakthrough capital growth - jammulinksnews.com
Is Mineralys Therapeutics Inc. a good long term investmentConsistently superior profits - jammulinksnews.com
What drives Mineralys Therapeutics Inc. stock priceTriple-digit return opportunities - Autocar Professional
9.66%
1.60%
자본화:
|
볼륨(24시간):